GEAI Congress - Autoimmune diagnostics in focus: multiple technologies shaped by real laboratory needs

Autoimmune diagnostics is rarely defined by a single marker, method or answer. Different clinical questions, marker profiles and laboratory workflows call for diagnostic approaches that are both scientifically robust and practical for everyday use. 

Recent expert discussions in Prague and Paris offered a timely opportunity to look at how this complexity is reflected in modern autoimmune testing — and why different laboratory needs call for a broad range of diagnostic technologies.

What we discussed at GEAI Congress in Paris

The GEAI Congress 2026 in Paris continued this expert dialogue in a more focused setting. As a French scientific meeting dedicated to autoimmunity, GEAI offered a space for clinically oriented discussions on autoimmune diseases, laboratory practice and diagnostic innovation.

At the BioVendor booth, the team presented selected autoimmune diagnostics solutions, including the Microblot-Array platform, CLIA technologies and ELISA assays. These conversations provided an opportunity to discuss not only individual technologies, but also their role in broader autoimmune diagnostic workflows.

For Laurent Augis, BioVendor Sales Manager for France, Luxembourg and Wallonia, GEAI once again proved to be a valuable scientific and professional meeting point.

“The GEAI Symposium is always an enriching experience, both personally and scientifically,” says Laurent Augis. “This year, we had valuable discussions around our MBA multiplex solution for the detection and quantification of autoantibodies, as well as our CLIA diabetes panel combining functional and autoimmune diabetes parameters.”

Held at the Institut Pasteur, a venue deeply rooted in scientific history, the congress provided a fitting setting for expert discussions on autoimmune diagnostics and innovation.

 

Listening to laboratories, developing relevant solutions

For BioVendor, expert congresses are not only about presenting technologies. They also provide a valuable opportunity to listen — to better understand what laboratories need, what challenges they face and how diagnostic solutions can support clinical practice.

The discussions in Prague and Paris reinforced the importance of developing diagnostic solutions that respond not only to scientific progress, but also to the practical needs of laboratories and clinicians.

“Scientific congresses provide much more than an overview of the latest research,” concludes Martina Hložánková. “They offer a unique opportunity to discuss unmet clinical needs directly with clinicians, laboratory specialists and key opinion leaders. For us, these interactions are invaluable because they help validate our development priorities and reveal how diagnostic technologies are being used in real-world practice.”

Explore our autoimmune diagnostics portfolio. Learn more about our CLIA solution for automated routine testing and Microblot-Array technology for multiparametric autoantibody profiling.

To read the full article : click here